Published in J Neurochem on March 01, 1981
Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies. J Neurochem (2011) 2.82
Characterisation of messenger RNA extracted post-mortem from the brains of schizophrenic, depressed and control subjects. J Neurol Neurosurg Psychiatry (1988) 0.94
Expressional potency of mRNAs encoding receptors and voltage-activated channels in the postmortem rat brain. Proc Natl Acad Sci U S A (1991) 0.86
Polyadenylated messenger RNA in paired helical filament-immunoreactive neurons in Alzheimer disease. Alzheimer Dis Assoc Disord (1990) 0.78
Limited predictability of postmortem human brain tissue quality by RNA integrity numbers. J Neurochem (2016) 0.76
Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol (1985) 7.93
Typing of human enteroviruses by partial sequencing of VP1. J Clin Microbiol (1999) 5.08
PCR amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria. J Clin Microbiol (1995) 4.27
Cefotaxime-resistant Nocardia asteroides strains are isolates of the controversial species Nocardia farcinica. J Clin Microbiol (1990) 4.16
Nosocomial outbreaks/pseudo-outbreaks caused by nontuberculous mycobacteria. Annu Rev Microbiol (1998) 3.84
Predictive testing for Huntington's disease with use of a linked DNA marker. N Engl J Med (1988) 3.82
DNA large restriction fragment patterns of sporadic and epidemic nosocomial strains of Mycobacterium chelonae and Mycobacterium abscessus. J Clin Microbiol (1993) 3.65
Translation of poliovirus RNA in vitro: changes in cleavage pattern and initiation sites by ribosomal salt wash. Virology (1979) 3.61
Human beta-globin messenger RNA. III. Nucleotide sequences derived from complementary DNA. J Biol Chem (1977) 3.55
Clinical and laboratory features of Nocardia nova. J Clin Microbiol (1991) 3.32
Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrob Agents Chemother (1994) 3.28
Rapid identification of clinically significant species and taxa of aerobic actinomycetes, including Actinomadura, Gordona, Nocardia, Rhodococcus, Streptomyces, and Tsukamurella isolates, by DNA amplification and restriction endonuclease analysis. J Clin Microbiol (1997) 3.12
Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother (1996) 2.92
Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis (1992) 2.78
Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol (1991) 2.70
Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann Neurol (1997) 2.64
Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry (1991) 2.55
New Nocardia taxon among isolates of Nocardia brasiliensis associated with invasive disease. J Clin Microbiol (1995) 2.52
Clinical significance, biochemical features, and susceptibility patterns of sporadic isolates of the Mycobacterium chelonae-like organism. J Clin Microbiol (1993) 2.40
A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae. J Infect Dis (1998) 2.34
Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients. Am J Respir Crit Care Med (1996) 2.30
Factors for the initiation of haemoglobin synthesis by rabbit reticulocyte ribosomes. Nature (1970) 2.27
Large DNA restriction fragment polymorphism in the Mycobacterium avium-M. intracellulare complex: a potential epidemiologic tool. J Clin Microbiol (1993) 2.25
Cell-free hemoglobin synthesis. II. Characteristics of the transfer ribonucleic acid-dependent assay system. J Biol Chem (1970) 2.24
Factors associated with slow progression in Huntington's disease. Arch Neurol (1991) 2.18
Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of Mycobacterium fortuitum. J Infect Dis (1991) 2.17
DNA amplification and restriction endonuclease analysis for differentiation of 12 species and taxa of Nocardia, including recognition of four new taxa within the Nocardia asteroides complex. J Clin Microbiol (1995) 2.16
Selective sparing of a class of striatal neurons in Huntington's disease. Science (1985) 2.16
Large restriction fragment patterns of genomic Mycobacterium fortuitum DNA as strain-specific markers and their use in epidemiologic investigation of four nosocomial outbreaks. J Clin Microbiol (1992) 2.07
Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease. Am J Respir Crit Care Med (1994) 1.97
Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy. Antimicrob Agents Chemother (1990) 1.96
Clinical application of PCR-restriction enzyme pattern analysis for rapid identification of aerobic actinomycete isolates. J Clin Microbiol (1998) 1.93
Nucleotide sequence of 3' untranslated portion of human alpha globin mRNA. Nucleic Acids Res (1977) 1.92
Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann Intern Med (1993) 1.90
Isoelectric focusing patterns of beta-lactamases in the rapidly growing mycobacteria. Tuber Lung Dis (1992) 1.89
An improved approach to prepare human brains for research. J Neuropathol Exp Neurol (1995) 1.84
Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch Gen Psychiatry (1986) 1.83
Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex. J Neurol Sci (1992) 1.79
Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid. Antimicrob Agents Chemother (1991) 1.78
Adverse events associated with high-dose rifabutin in macrolide-containing regimens for the treatment of Mycobacterium avium complex lung disease. Clin Infect Dis (1995) 1.78
Recognition of a Nocardia transvalensis complex by resistance to aminoglycosides, including amikacin, and PCR-restriction fragment length polymorphism analysis. J Clin Microbiol (1997) 1.77
Magic numbers in exotic nuclei and spin-isospin properties of the NN interaction. Phys Rev Lett (2001) 1.73
Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis. Am J Respir Crit Care Med (1998) 1.71
Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci (1992) 1.68
Report on an outbreak of postinjection abscesses due to Mycobacterium abscessus, including management with surgery and clarithromycin therapy and comparison of strains by random amplified polymorphic DNA polymerase chain reaction. Clin Infect Dis (1997) 1.67
Maternal transmission in Huntington's disease. Lancet (1983) 1.64
Nosocomial outbreak of respiratory tract colonization with Mycobacterium fortuitum: demonstration of the usefulness of pulsed-field gel electrophoresis in an epidemiologic investigation. Am Rev Respir Dis (1991) 1.64
The primary structure of Bacillus subtilis and Bacillus stearothermophilus 5 S ribonucleic acids. J Biol Chem (1976) 1.64
Clinical and neuropathologic assessment of severity in Huntington's disease. Neurology (1988) 1.62
'Magic' nucleus 42Si. Nature (2005) 1.62
Molecular mechanisms of clarithromycin resistance in Mycobacterium avium: observation of multiple 23S rDNA mutations in a clonal population. J Infect Dis (1996) 1.61
Evidence for the GluR6 gene associated with younger onset age of Huntington's disease. Neurology (1999) 1.60
Tetracycline resistance determinants in Mycobacterium and Streptomyces species. Antimicrob Agents Chemother (1994) 1.59
BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata. Antimicrob Agents Chemother (1989) 1.58
Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. Brain (1974) 1.57
Discovery of 40Mg and 42Al suggests neutron drip-line slant towards heavier isotopes. Nature (2007) 1.57
Human brain dopamine receptors in children and aging adults. Synapse (1987) 1.55
A sex related factor in the inheritance of Huntington's chorea. Ann Hum Genet (1974) 1.51
Acquired resistance of Nocardia brasiliensis to clavulanic acid related to a change in beta-lactamase following therapy with amoxicillin-clavulanic acid. Antimicrob Agents Chemother (1991) 1.48
Randomly amplified polymorphic DNA PCR for comparison of Mycobacterium abscessus strains from nosocomial outbreaks. J Clin Microbiol (1997) 1.47
Quantitative neuropathological changes in presymptomatic Huntington's disease. Ann Neurol (2001) 1.44
Surgical management of polypoid lesions of the gallbladder. Br J Surg (2000) 1.41
First observation of ground state dineutron decay: 16Be. Phys Rev Lett (2012) 1.40
Adenomatous polyposis arising after the age of 53. J R Soc Med (1987) 1.39
Distribution of metastases at necropsy in colorectal cancer. Clin Exp Metastasis (1986) 1.39
An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients. Arch Gen Psychiatry (1987) 1.38
The amyloid beta protein gene is not duplicated in brains from patients with Alzheimer's disease. Science (1987) 1.35
The central proline of an internal viral fusion peptide serves two important roles. J Virol (2000) 1.33
A corticosteroid/dopamine hypothesis for psychotic depression and related states. J Psychiatr Res (1985) 1.33
Comparison of the rotavirus gene 6 from different species by sequence analysis and localization of subgroup-specific epitopes using site-directed mutagenesis. Virology (1997) 1.32
Partial characterization of Nocardia farcinica beta-lactamases. Antimicrob Agents Chemother (1993) 1.31
Morphometric analysis of the prefrontal cortex in Huntington's disease. Neurology (1991) 1.30
Primary structure at the site in beef and wheat elongation factor 2 of ADP-ribosylation by diphtheria toxin. FEBS Lett (1979) 1.29
Cell-free hemoglobin synthesis in beta-thalassemia. Proc Natl Acad Sci U S A (1970) 1.28
Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus. J Neuropathol Exp Neurol (1991) 1.27
Nucleotide sequences of human globin messenger RNA. Proc Natl Acad Sci U S A (1974) 1.26
Proteolytic dissection of Zab, the Z-DNA-binding domain of human ADAR1. J Biol Chem (1999) 1.25
Regional mitochondrial respiratory activity in Huntington's disease brain. J Neurochem (1985) 1.25
Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum. J Clin Microbiol (1999) 1.25
Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex. Clin Infect Dis (2000) 1.24
Controlled trial of the introduction of a robotic camera assistant (EndoAssist) for laparoscopic cholecystectomy. Surg Endosc (2002) 1.24
Reduced serum levels of clarithromycin in patients treated with multidrug regimens including rifampin or rifabutin for Mycobacterium avium-M. intracellulare infection. J Infect Dis (1995) 1.23
Nucleotide sequences of human globin messenger RNA. Ann N Y Acad Sci (1974) 1.22
Cytosine-cytosine+ base pairing stabilizes DNA quadruplexes and cytosine methylation greatly enhances the effect. Biochemistry (1993) 1.21
Late-onset Hallervorden-Spatz disease presenting as familial parkinsonism. Neurology (1985) 1.21
Production and characterization of a soluble, active form of Tva, the subgroup A avian sarcoma and leukosis virus receptor. J Virol (1999) 1.21
Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases. Neuropsychopharmacology (1987) 1.20
Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia. Proc Natl Acad Sci U S A (1996) 1.19
Basic fibroblast growth factor in Alzheimer's disease. Biochem Biophys Res Commun (1990) 1.19
Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid. J Neurochem (1990) 1.19
Early posttranslational modifications of the three neurofilament subunits in mouse retinal ganglion cells: neuronal sites and time course in relation to subunit polymerization and axonal transport. Brain Res Mol Brain Res (1989) 1.19
Alzheimer's disease brain: alterations in RNA levels and in a ribonuclease-inhibitor complex. Science (1984) 1.18
Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin. Brain Res (1990) 1.18
Multisite reproducibility of Etest for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum. J Clin Microbiol (2000) 1.18
Late onset of Huntington's disease. J Neurol Neurosurg Psychiatry (1985) 1.18
Controlled intraoperative water testing of left-sided colorectal anastomoses: are ileostomies avoidable? Ann R Coll Surg Engl (1999) 1.17
Preparation of RNA transcripts of discrete segments of DNA. Methods Enzymol (1974) 1.17
Isolation of Arabidopsis mutants altered in the light-regulation of chalcone synthase gene expression using a transgenic screening approach. Plant J (1995) 1.16
Reduced neuronal size in posterior hippocampus of schizophrenic patients. Schizophr Bull (1991) 1.15
Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain. Ann Neurol (1983) 1.15